SS
Suraj Singh Wadhawa
About Suraj Singh Wadhawa
Data last updated:
Suraj Singh Wadhawa is a Designated Partner at Fil Pharmaceuticals Llp (since 2024) and Director at Shree Ganpati Bhaskar Health Care Private Limited (since 2021). The companies operate in Pharma and Healthcare.
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Fil Pharmaceuticals Llp ACH-6756 | Designated Partner | 10 Jun 2024 | 2024 | Active | |
| Shree Ganpati Bhaskar Health Care Private Limited U85190CT2021PTC011228 | Director | 02 Feb 2021 | 2021 | Active |
Board colleagues of Suraj Singh Wadhawa
| Name | DIN | Company | Designation |
|---|---|---|---|
| Nirmala Hinduja | 10662821 | Fil Pharmaceuticals Llp | Designated Partner |
| Vivek Wadhawa | 09050134 | Fil Pharmaceuticals Llp , Shree Ganpati Bhaskar Health Care Private Limited | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Suraj Singh Wadhawa
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Suraj Singh Wadhawa
Suraj Singh Wadhawa currently holds 2 directorships: Fil Pharmaceuticals Llp (Designated Partner, since 10 Jun 2024); Shree Ganpati Bhaskar Health Care Private Limited (Director, since 02 Feb 2021).
Suraj Singh Wadhawa was first appointed on 02 Feb 2021 as Director at Shree Ganpati Bhaskar Health Care Private Limited. The most recent appointment on record is 10 Jun 2024 at Fil Pharmaceuticals Llp.
The current boards of Suraj Singh Wadhawa's companies include Nirmala Hinduja (Fil Pharmaceuticals Llp), Vivek Wadhawa (Fil Pharmaceuticals Llp).